home / stock / agn:cc / agn:cc quote
Last: | $5.87 |
---|---|
Change Percent: | 12.88% |
Open: | $5.38 |
Close: | $5.87 |
High: | $5.87 |
Low: | $5.38 |
Volume: | 2,110 |
Last Trade Date Time: | 05/06/2022 04:56:53 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.87 | $5.38 | $5.87 | $5.87 | $5.38 | 2,110 | 05-06-2022 |
$5.2 | $5.24 | $5.2 | $5.8 | $5.2 | 4,922 | 05-05-2022 |
$5.25 | $4.99 | $5.25 | $5.25 | $4.89 | 11,619 | 05-04-2022 |
$4.78 | $4.845 | $4.78 | $4.98 | $4.68 | 13,843 | 05-03-2022 |
$4.42 | $4.12 | $4.42 | $4.42 | $4 | 9,815 | 05-02-2022 |
$4.11 | $4.5 | $4.11 | $4.55 | $4.1 | 2,836 | 04-29-2022 |
$4.6 | $5.15 | $4.6 | $5.16 | $4.6 | 3,046 | 04-28-2022 |
$5.05 | $5.14 | $5.05 | $5.15 | $5.05 | 2,755 | 04-27-2022 |
$5.23 | $5.55 | $5.23 | $5.55 | $5.01 | 7,653 | 04-26-2022 |
$5.69 | $5.79 | $5.69 | $5.79 | $5.36 | 1,399 | 04-25-2022 |
$5.81 | $5.88 | $5.81 | $5.88 | $5.81 | 903 | 04-22-2022 |
$5.82 | $5.82 | $5.82 | $5.95 | $5.8 | 9,052 | 04-21-2022 |
$5.99 | $5.84 | $5.99 | $5.99 | $5.83 | 649 | 04-20-2022 |
$6 | $5.8 | $6 | $6 | $5.8 | 1,931 | 04-19-2022 |
$5.81 | $5.83 | $5.81 | $6 | $5.8 | 5,193 | 04-18-2022 |
$5.88 | $5.89 | $5.88 | $5.95 | $5.88 | 963 | 04-15-2022 |
$5.88 | $5.89 | $5.88 | $5.95 | $5.88 | 928 | 04-14-2022 |
$5.93 | $6.29 | $5.93 | $6.29 | $5.89 | 1,812 | 04-13-2022 |
$6.05 | $6.19 | $6.05 | $6.29 | $6.05 | 8,951 | 04-12-2022 |
$6.12 | $6.1 | $6.12 | $6.14 | $6.05 | 1,803 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Algernon Pharmaceuticals Inc. Company Name:
AGN:CC Stock Symbol:
CNQC Market:
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to invite investors and other interested parties to participate in an upcoming speci...
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it pl...